BLTE

Conviction 42HealthcareScan · Mon, Aug 10, 2026

BLTE$166.87+2.34%

ResistanceSupportVol 14Insider sell

Vol MA14 155.55K

May 11May 28Jun 16Jul 6Jul 23Aug 10

BELITE BIO, INCBiotechnologywww.belitebio.com ↗

Price166.87

Change+2.34%

Gap-0.50%

Rel volume0.64×

Avg volume153.51K

Avg $ vol23.97M

SMA 20156.20

SMA 50149.95

SMA 200152.27

Price vs 50+11.28%

Price vs 200+9.59%

MA stackmixed

50/200 cross—

Supertrendup · 147.53

RSI (14)63

MACD hist0.76

MACD cross—

Stoch %K / %D97 / 90

ADX (14)17

+DI / −DI25 / 12

RSI divergence—

MACD divergence—

ATR %+3.64%

ADR %3.54%

52w high190.30

52w low61.81

From 52w high-12.31%

Above 52w low+169.96%

New 52w highNo

SqueezeOff

Bollinger width12.49%

%B1.05

Donchian pos97.92%

Donchian high167.35

Donchian low144.06

AVWAP (52w high)158.63

vs AVWAP high+5.19%

AVWAP (52w low)149.38

vs AVWAP low+11.71%

OBV trendFlat

Chaikin MF (20)0.10

Today vs 20d0.64×

Avg vol (14d)155.54K

Avg vol (20d)153.51K

Avg $ vol (20d)23.97M

Market cap6.56B

RS 3m (vs SPY)-1.18%

RS 6m (vs SPY)-22.68%

RS line new highNo

Trend template6/8

Technical rank62.0

1 week+7.80%

1 month+11.74%

3 months+7.74%

6 months-11.18%

1 year+138.07%

YTD+4.77%

P/E—

P/B8.52

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current50.02

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target216.20

Target upside29.57%

Analyst ratingBuy

Institutional22.85%

Ent. value6.21B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out40.09M

Employees41

ListedFri, Apr 29, 2022

Free float18.44M

Float %46.0%

Short interest1.32M

Days to cover7.1d

Short volume44.1%

Squeeze score42 / 100

Next earningsThu, Aug 13, 2026 · after (3d)

EPS forecast−$0.73 · 3 est

Last EPS vs est−$0.34 vs −$0.60

Last surprise+43.3% beat

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank62.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance162.20

Support142.52

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in BLTE

All disclosures →

No recent disclosed trades by Congress in BLTE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BLTE · 10 sells

Insider	Side	Shares	Value	Traded	Filed
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	96	$14K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	3.75K	$542K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	4.86K	$707K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	1.2K	$175K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	96	$14K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	3.14K	$438K	2026-06-16	2026-06-17
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	2.05K	$283K	2026-06-16	2026-06-17
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	784	$108K	2026-06-16	2026-06-17
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	540	$76K	2026-06-16	2026-06-17
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	100	$14K	2026-06-16	2026-06-17

SEC filings

EDGAR filings in BLTE · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.